HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

NEO 6002

a gemcitabine-cardiolipin conjugate with antineoplastic activity; structure in first source

Also Known As:

NEO-6002; NEO6002

Networked: 1 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Ahmad, Imran: 1 article (01/2006)
2.	Ahmad, Moghis U: 1 article (01/2006)
3.	Ali, Shoukath M: 1 article (01/2006)
4.	Chen, Paul: 1 article (01/2006)
5.	Chien, Pei-Yu: 1 article (01/2006)
6.	Khan, Abdul R: 1 article (01/2006)
7.	Sheikh, Saifuddin: 1 article (01/2006)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2006 - "We conclude that NEO6002 may be an effective chemotherapeutic agent with improved tolerability and can potentially circumvent NT-deficient, gemcitabine-resistant tumors." 01/01/2006 - "At a dose of 18 micromol/kg, NEO6002 inhibited the growth of BxPC-3 xenografts by 52%, while only 32% of tumor inhibition was achieved with gemcitabine. "
2.	Body Weight (Weight, Body) 01/01/2006 - "At the in-vivo level, a comparative toxicity study showed a significant body weight loss and a decrease in white blood cell counts in gemcitabine-treated mice, whereas the influence of NEO6002 was mild. "

Related Drugs and Biologics

1.	Gemcitabine